Huajin Pharmaceutical was selected as the "Leader" List of Enterprises to be Listed in Guangzhou in 2022

December 9, 2022, the results of the "leader" selection of Guangzhou's proposed listed enterprises were announced, and Huajin Pharmaceutical was successfully selected into the "TOP10 of Guangzhou's Most Capital Concerned Leading Enterprises in 2022" list.

this selection, after enterprise declaration, data verification, quantitative preliminary screening, enterprise visits, re-evaluation by the evaluation team and other links, the list of "TOP10 enterprises with the most capital attention in Guangzhou in 2022" and "TOP10 enterprises with the most growth in Guangzhou in 2022" were finally selected.

Huajin Medicine is the world's first (first-in-class) development enterprise of bacterial vector genetic engineering biological products targeting the regulation of tumor amino acid metabolism. The core product oncolytic bacterium SGN1 (Samwick®,SalMet-Vec®) is carrying out Phase I/IIa registered clinical trials of intravenous and intratumoral administration for broad-spectrum solid tumors in the United States and Taiwan, China. This entry into the list is an affirmation of Huajin Pharmaceutical's development achievements, and will also encourage the company to accelerate its progress towards the dual goals of product listing and enterprise listing.

2022 Guangzhou to be listed on the enterprise "leader" selection profile

In order to further explore and cultivate a group of outstanding companies to be listed with the attribute of "leader", broaden the financing channels for companies to be listed, and improve the capital market service system, under the guidance and support of the Guangzhou Local Financial Supervision Administration, from June to December 2022, Sponsored by Guangzhou Financial Development Service Center, Industrial and Commercial Bank of China Guangzhou Branch and Guangdong Equity Exchange Center, China Merchants Securities co-organized the 2022 Guangzhou "Leader" selection activity. In this selection activity, financial experts from Guangzhou Capital Market Bank, well-known private equity investment institutions, securities companies, industry associations and other institutions were invited to serve as judges to select candidates from multiple dimensions such as technological innovation, capital attention, and corporate growth. Enterprises are classified and selected.